Even SUs, whose role in T2D therapy is gradually losing ground, have been shown to possess anti-inflammatory properties [39]. Although insulin is also known to exhibit anti-inflammatory actions, these are short-term and can be counteracted in the long term by increasing body weight that fuels the vicious cycle of inflammation [40]. The gene discussed is INS; the disease is type 2 diabetes mellitus.